Colchicine-resistant familial Mediterranean fever in a renal transplantation patient: successful treatment with anakinra

Affiliations

¹ Nephrology Department , Ankara University School of Medicine, Sİna Hospital , Ankara , Turkey.
² Rheumatology Department , Ankara University School of Medicine , Ankara , Turkey.
³ General Surgery Department , Ankara University School of Medicine , Ankara , Turkey.

Zeynep Kendi Celebi et al. Clin Kidney J. 2014 Apr.

. 2014 Apr;7(2):219-20.

doi: 10.1093/ckj/sft164. Epub 2014 Jan 12.

¹ Nephrology Department , Ankara University School of Medicine, Sİna Hospital , Ankara , Turkey.
² Rheumatology Department , Ankara University School of Medicine , Ankara , Turkey.
³ General Surgery Department , Ankara University School of Medicine , Ankara , Turkey.

No abstract available

Figures

1. Tuglular S, Yalcinkaya F, Paydas S, et al. A retrospective analysis for aetiology and clinical findings of 287 secondary amyloidosis cases in Turkey. Nephrol Dial Transplant. 2002;17:2003–2005. - PubMed
1. Ben-Chetrit E, Ozdogan H. Non-response to colchicine in FMF—definition, causes and suggested solutions. Clin Exp Rheumatol. 2008;26(Suppl 50):S49–S51. - PubMed
1. Seyahi E, Ozdogan H, Celik S, et al. Treatment options in colchicine resistant familial Mediterranean fever patients: thalidomide and etanercept as adjunctive agents. Clin Exp Rheumatol. 2006;24(Suppl 42):S99–103. - PubMed
1. Baykal Y, Saglam K, Yilmaz MI, et al. Serum sIL-2r, IL-6, IL-10 and TNF-alpha level in familial Mediterranean fever patients. Clin Rheumatol. 2003;22:99–101. - PubMed
1. Alpay N, Sumnu A, Calışkan Y, et al. Efficacy of anakinra treatment in a patient with colchicine-resistant familial Mediterranean fever. Rheumatol Int. 2012;32:3277–3279. - PubMed